BRACHYTHERAPY IN SKING CANCER
Silvia Rodriguez MD. PhD. Instituto para el tratamiento integral del cáncer ITIC. - Hospital Clínica Benidorm (Alicante)

ERLOTINIB AND CHEMORADIATION IN PATIENTS WITH SURGICALLY RESECTED LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN): A GICOR PHASE I TRIAL
F. Arias de la Vega1*, I. Herruzo2, M. de las Heras3, A. de la Torre4, V. Arrazubi1, J. Contreras2, I. Prieto5, J. A. García Saenz3, J. Romero4, F. A. Calvo5

POSTER ESMO 2008. “LONG-TERM VERSUS SHORT-TERM ANDROGEN DEPRIVATION COMBINED WITH HIGH-DOSE CONFORMAL RADIOTHERAPY FOR PATIENTS WITH LOCALIZED PROSTATE CANCER: FIRST REPORT ON COMPLIANCE, FEASIBILITY
A. Zapatero, A. Alvarez, X. Maldonado, A. Guerrero, V. Macías, A. Cabeza, C. González San-Segundo, F. Casas, A. Pedro Olivé, F.A. Calvo

Guía Terapéutica de Soporte en Oncología adioterápica (509 pág). Ed. Masson. Barcelona 2004. ISBN:84-458-1419-2
PÉREZ ROMASANTA LA, CALVO FA

Pathologic downstaging of T3-4Nx rectal cancer after chemoradiation: 5-Fluorouracil vs Tegafur. Int J Radiat Oncol Biol Phys 51: 1264 - 1270, 2001. FI: 4.556
CALVO FA, GÓMEZ-ESPI M, DÍAZ-GONZÁLEZ JA, CANTALAPIEDRA R, MARCOS P, ALVARADO A, GARCÍA-ALFONSO P, HERRANZ R, ÁLVAREZ E.

Intraoperative presacral electron boost following preoperative chemoradiation in T3-4Nx rectal cancer: initial local effects and clinical outcome analysis. Radiother Oncol 62:201-206, 2002. FI: 3.304
CALVO FA, GÓMEZ-ESPI M, DÍAZ GONZÁLEZ JA, ALVARADO A, CANTALAPIEDRA R, MARCOS P, MATUTE R, MARTINEZ NE, LOZANO MA, HERRANZ R

18F-FDG Positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58:528-535, 2004. FI: 4.556
CALVO FA, DOMPER M, MATUTE R, MARTÍNEZ-LÁZARO R, ARRANZ JA, DESCO M, ÁLVAREZ E, CARRERAS JL

Neoadjuvant chemoradiation with Tegafur in cancer of the pancreas. Initial analysis of clinical tolerance and outcome. Am J Clin Oncol 27:343-349, 2004. FI: 1.615
CALVO FA, MATUTE R, GARCÍA-SABRIDO JL, GÓMEZ-ESPÍ M, MARTÍNEZ N, LOZANO MA, HERRANZ R

Preoperative chemoradition with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer. Int J Radiat Oncol Biol Phys 61:1378-1384, 2005. FI: 4.556
DÍAZ-GONZÁLEZ JA, CALVO FA, CORTÉS J, DE LA MATA D, GÓMEZ-ESPÍ M, LOZANO MA, LOZANO E, SERRANO J, HERRANZ R

Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: does radiation dose influence out come of patients treated with adjuvant androgen deprivat
ZAPATERO A, VALCARCEL F, CALVO FA, ALGAS R, BEJAR A, MALDONADO J, VILLÁ S

Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation, surgery and intraoperative irradiation. Int J Radiat Oncol Biol Phys 64
DÍAZ-GONZÁLEZ JA, CALVO FA, CORTÉS J, GARCÍA-SABRIDO JL, GÓMEZ-ESPÍ M, DEL VALLE E, MUÑOZ-JIMÉNEZ F, ÁLVAREZ E

Improved incidence of p T0 downstaged surgical specimen in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoraditation. Ann Oncol 17:1
CALVO FA, SERRANO FJ, DÍAZ-GONZÁLEZ JA, GÓMEZ-ESPÍ M, LOZANO E, GARCÍA R, DE LA MATA D, ARRANZ JA, GARCÍA-ALFONSO P, PÉREZ-MANGA G, ÁLVAREZ E

A large, multinational, prospective survey defining the prevalence, incidence and treatment of anemia in cancer patients. Eur J Cancer 40:2293-2306, 2004 FI: 3.806
EUROPEAN CANCER ANEMIA SURVEY (ECAS)

- The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, restrospective analysis
JORDI GIRALT, MANUEL DE LAS HERAS, LAURA CEREZO, ARANZAZU ERASO, EDUARDO HERMOSILLA, DOLORES VELEZ, JUAN LUJAN, ELOI ESPIN, JOSE ROSSELLO, JOAQUIN MAJÓ, SERGI BENAVENTE, MANEL ARMENGOL, I. DE TORRES, ON BEHALF OF THE GRUPO ESPAÑOL DE INVESTIGACIÓN CLÍNICA EN ONCOLOGÍA RADIOTERÁPICA (GICOR)

- Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck
A. BIETE SOLÀ, J. MARRUECOS QUEROL, F.A. CALVO MANUEL, E. VERGER FRANSOY, À. ROVIROSA CASINO, J.J. GRAU DE CASTRO, M. DE LAS HERAS GONZÁLEZ, A. RAMOS AGUERRI, A. PALACIOS EITO, C. VEIRAS CANDAL AND Mª. V. SOLANO LÓPEZ

- Predictive factors in advanced head and neck cancer treated by radio-chemotherapy and hypoxia modification
B. Clavo, F. Robaina, A. Ruiz, M. Lloret, D. Macias, J. Rivero, B. Pinar, S. Quintero, J. M. Cuyas and M. A. Hernandez
Dr. Negrin University Hospital, Las Palmas, Spain